Please use this identifier to cite or link to this item:
|Title:||Malignant ovarian germ-cell tumours|
|Authors:||Low, J.J.H. |
malignant ovarian germ-cell tumour
|Citation:||Low, J.J.H., Ilancheran, A., Ng, J.S. (2012-06). Malignant ovarian germ-cell tumours. Best Practice and Research: Clinical Obstetrics and Gynaecology 26 (3) : 347-355. ScholarBank@NUS Repository. https://doi.org/10.1016/j.bpobgyn.2012.01.002|
|Abstract:||Malignant ovarian germ-cell tumours account for about 5% of all ovarian malignancies and typically present in the teenage years. They are almost always unilateral and are exquisitely chemosensitive. As such, the surgical approach in young women with such tumours confined to a single ovary should aim to preserve fertility. In early disease, a unilateral salpingo-oophorectomy with careful surgical staging is of great importance in selecting appropriate adjuvant therapy. In advanced disease, the role of aggressive cytoreducation is not well defined, and removal of both ovaries does not confer improvement in outcome. Bleomycin, etoposide and cisplatin combination chemotherapy is regarded as the gold standard for adjuvant therapy. Studies evaluating ovarian and reproductive capacity after conservative surgery and chemotherapy for malignant ovarian germ-cell tumours have consistently demonstrated excellent prognosis, with the return of normal menstrual function and fertility rates in these women with no increase in the risk of teratogenicity. © 2012 Elsevier Ltd. All rights reserved.|
|Source Title:||Best Practice and Research: Clinical Obstetrics and Gynaecology|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on May 19, 2018
WEB OF SCIENCETM
checked on Apr 2, 2018
checked on May 3, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.